DAVIS JOHN C. JR 4
4 · Magenta Therapeutics, Inc. · Filed Apr 16, 2020
Insider Transaction Report
Form 4
DAVIS JOHN C. JR
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-04-14+50,000→ 50,000 totalExercise: $8.18Exp: 2030-04-13→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on April 14, 2020.